dc.creatorFernandes
dc.creatorMiriam R.; Ignacio
dc.creatorAline; Rodrigues
dc.creatorViviane A. A.; Groppo
dc.creatorFranciso C.; Cardoso
dc.creatorAry L.; Avila-Campos
dc.creatorMario J.; Nakano
dc.creatorViviane
dc.date2017
dc.datejan
dc.date2017-11-13T13:14:44Z
dc.date2017-11-13T13:14:44Z
dc.date.accessioned2018-03-29T05:52:27Z
dc.date.available2018-03-29T05:52:27Z
dc.identifierMicrobial Drug Resistance. Mary Ann Liebert Inc, v. 23, p. 56 - +, 2017.
dc.identifier1076-6294
dc.identifier1931-8448
dc.identifierWOS:000391745500009
dc.identifier10.1089/mdr.2015.0320
dc.identifierhttp://online.liebertpub.com/doi/abs/10.1089/mdr.2015.0320
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/327233
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1364258
dc.descriptionConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.descriptionFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.descriptionThe administration of antimicrobial agents leads to an ecological imbalance of the host-microorganisms relationship, and it causes a rapid and significant reduction in the microbial diversity. The aim of the current study was to evaluate the impact of antibiotic therapy on intestinal microbiota of children between 3 and 12 years of age. The fecal samples were collected from hospitalized children (n = 31) and from healthy untreated children (n = 30). The presence of bacteria and their quantities were assessed by culture-based methods and quantitative polymerase chain reaction (qPCR). By culture method, in the children receiving antibiotics, a low recovery of Bifidobacterium spp. (54.8%), Bacteroides spp./Parabacteroides spp. (54.8%), Clostridium spp. (35.5%), and Escherichia coli (74.2%) was observed compared with the children without antibiotic therapy (100%, 80%, 63.3%, and 86.6%, respectively). By qPCR, the children receiving antibiotics showed a lower copy number for all microorganisms, except to Lactobacillus spp. (p = 0.0092). In comparison to the nontreated children, the antibiotic-treated children showed a significantly lower copy number of Bifidobacterium spp. (p = 0.0002), Clostridium perfringens (p < 0.0001), E. coli (p = 0.0268), Methanobrevibacter smithii (p = 0.0444), and phylum Firmicutes (p = 0.0009). In conclusion, our results obtained through qualitative and quantitative analyses, demonstrate that antibiotic therapy affect the intestinal microbiome of children.
dc.description23
dc.description1
dc.description56
dc.description+
dc.descriptionCNPq [158799/2012-7]
dc.descriptionFAPESP [2013/17739-9]
dc.descriptionConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.descriptionFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.languageEnglish
dc.publisherMary Ann Liebert Inc
dc.publisherNew Rochelle
dc.relationMicrobial Drug Resistance
dc.rightsfechado
dc.sourceWOS
dc.subjectMicrobiome
dc.subjectAntibiotic Therapy
dc.subjectChildren
dc.subjectAnaerobic Bacteria
dc.subjectEscherichia Coli
dc.titleAlterations Of Intestinal Microbiome By Antibiotic Therapy In Hospitalized Children
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución